[{"title": "BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPZ1FkbWlsN3lvc3Rsc2FqY2ZHQXRSaVlJTi1kR0ozUnU2M1Uyck1vSmFKcmFXQjFPS2MxRy0zdmpuNndSTGJwOFRZdXE5WVg1MWg1cXEzSXBWYno4NXVTckEyYUdGRW02ZmxITGZMelpNdEJLSERUOGx2Mm54UXNMdHJZc01rMW9UWHVB?oc=5\" target=\"_blank\">BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Tue, 12 Aug 2025 19:00:03 GMT"}, {"title": "BioXcel Therapeutics to Participate in the H.C. Wainwright & Co. \u201cHCW@Home\u201d Series - GlobeNewswire", "description": "<a href=\"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOUXpjWWM1cWZiemdnR2JVR0NxUG53Nk5fbFlQb2RHVHYzUzU3V3VFbHlxVlhxYmNhS1JoSnhWa0dIbWdacmwwTmJzYkpsSWFFOXd0N2tBSkFzSFB1aVVUS0Zkbl8wUGZXNHU3cHJ5b1BFcGtJOVhGWkNfeV9XX0c2TGpXTExtWlIwOEJjZmNyYUw3TFhZV181Tkt4NHNZNWpyZ1dpZnlMWkpDS0FmUnBsYXBxeTB2U21lTEF2Q0Fyb0NYUzFPOFpHc09SWW5lU0pDT0d3YkdUd1BBX3hPS2NKVWxn?oc=5\" target=\"_blank\">BioXcel Therapeutics to Participate in the H.C. Wainwright & Co. \u201cHCW@Home\u201d Series</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GlobeNewswire</font>", "publishedAt": "Wed, 13 Aug 2025 11:01:21 GMT"}, {"title": "BioXcel Therapeutics Stock Soars Amid Positive Clinical and Patent Developments - StocksToTrade", "description": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxNcTdiT3BlTjQtcjJZajJGRUt3R2sxT0pqNDBPdjhMdnp1VUU5LVhXeUkyd2I2aTd2cWozaUFDNWRqczBobFltSDdpZHVpTjFuWXZKdEQ5RnBFM0ZVVERuVE9kYnVBNk9rY1cwSUJreXU1WTVVQ2VNeXY5d1pocXFWZXNlUQ?oc=5\" target=\"_blank\">BioXcel Therapeutics Stock Soars Amid Positive Clinical and Patent Developments</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">StocksToTrade</font>", "publishedAt": "Tue, 12 Aug 2025 16:03:00 GMT"}, {"title": "BioXcel Therapeutics Reports Upcoming Topline Data from SERENITY At-Home Phase 3 Trial and Strengthens Financial Position - Quiver Quantitative", "description": "<a href=\"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQUXc2SmdxUWpsSW91Q1BiU19ORWNGVHdNX1VYVEUzdlNlQURZUTNNcVRXLWpVTjZHbmM0Qy04MTc4Qnl3Sm9IamRzVlBVR09JSENLaFowSHFDVGlSVFhMX01pckFGYnZsRjRtZUkwQjYyOENlN1dJdENpMVlnTVJvNGVsSGRNYk5yUmVBOVNaSmVxdFpDa0FJQ1c2OVE1cUY4Q29qX01EVEhwaVgzZ3BEU2dQa1pnbEVhRm91aGVxQVNvdjg5OFh0NXF5dmxQUy0zRnA1eTgwb1FsWnpMdkNYUnRERTJ1TnBRYkE?oc=5\" target=\"_blank\">BioXcel Therapeutics Reports Upcoming Topline Data from SERENITY At-Home Phase 3 Trial and Strengthens Financial Position</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Quiver Quantitative</font>", "publishedAt": "Tue, 12 Aug 2025 12:00:00 GMT"}, {"title": "Is BioXcel Therapeutics Inc. part of any major index - Trade Volume Summary & AI Enhanced Market Trend Forecasts - thegnnews.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxOT3hFSXF5cjBTWWZYMUE1TzVwamFheTFaaG9FdWIzNndJMGNzWS1xVFhYYWYyWkhkMlNBN3dSV0NjVzJZOVc2czE2a2dDeUxyLTdocXI2czctSlNLLXczY1UzZzZMenE2LXNybk5uTG95THA5MC1wVHcxdlhXUnRLMFdLQjg4T3dlbFZCTA?oc=5\" target=\"_blank\">Is BioXcel Therapeutics Inc. part of any major index - Trade Volume Summary & AI Enhanced Market Trend Forecasts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">thegnnews.com</font>", "publishedAt": "Fri, 15 Aug 2025 15:30:57 GMT"}, {"title": "BioXcel Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView", "description": "<a href=\"https://news.google.com/rss/articles/CBMi7gFBVV95cUxQSml6c3M1eW9Vdkh4ZldkeUlJN1lhSXdONnZpcng3WHh2RVZ6TFh0akJweVJURnc0TUJBTWpfcVlpRkN2MlM3dUdROUp1SlNfdVdPSURGUHM3cEptTWNoU1phX0dseTdKMWd1Sm10Q1p0endGTEtSTk4tUlhhUmpkdGpncFFvTWVEQjhOX2hQX3gyRTJZRlJBWFZDMlIzQmo1N1JQYUN3eHhOaHlub3QyZnQwOW1uMDJEVmZlVGUzZ29TYnBqRkJJd0xwN0IzUmhQaldxX2RacDVYMUp5Y0N1MzVoMzVwNVBBcmJNMkhB?oc=5\" target=\"_blank\">BioXcel Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>", "publishedAt": "Tue, 12 Aug 2025 13:58:10 GMT"}, {"title": "BioXcel Therapeutics Receives Positive FDA Feedback - TipRanks", "description": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxNYktIcnJtSFhkRGNiQ0lRXzdwU3V4VE9mUUxOYzFEQkd3eUNDMG5hdlVjUVRCNV9xV3pKZTl1R25Zbm12Ty1vSVBmWElXdk4xRUEyMFZoN09uejk0b1FIY1RpT3BwOVVpaDk3YXR1aFk0UVpnczJYdzRDRUwzWGNSMmlrSm5HVkRhOXphMkNWOVh5Tko3SERtV2VQM3NtM095b3k1ZU5B?oc=5\" target=\"_blank\">BioXcel Therapeutics Receives Positive FDA Feedback</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>", "publishedAt": "Fri, 15 Aug 2025 13:52:30 GMT"}, {"title": "BioXcel Therapeutics Reports Q2 2025 Financial Results - TipRanks", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNYzlaZ2RLbGc0QzZXcWtpak1hZW5mYTRLVXVsWUFydnh5cEw0QWVCWlBkeXRsekdlTDYwYTNCVXhNVERtWEVWY242SHFGLV94UC1NTGFmR1VqMWRYMF9CaHVQS0I2LV9LaFp4dWZzeWN0RjlQX3FBZUZlNnJnaVY2Vm9oNDlfWkJZb3UwXzRPVjNiLVo3SGtEU3NKYTFMcndXUVpqQV81RzNEdw?oc=5\" target=\"_blank\">BioXcel Therapeutics Reports Q2 2025 Financial Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>", "publishedAt": "Wed, 13 Aug 2025 04:14:09 GMT"}, {"title": "BioXcel Therapeutics CEO Discusses AI-Driven Neuroscience Pipeline at Virtual Investor Event - Stock Titan", "description": "<a href=\"https://news.google.com/rss/articles/CBMivAFBVV95cUxQN242LS00XzItYzZ3S0VCeUZoQUtCUkVpZVhvZTYzTnNOVGJrQlRIQjgxc0Z5MmlIVUZnOFlKcW5wMmZWbUJ0ZE9YQ3pRRnlVS0s3ajJ3LTlnWXV5dHBqNGxOUmI3eWRBNTZSc2duYkJzcDVmNFdSUkU1eVBQcnBfTTNaeXNZTXBiX29RVWg5SzlKLXdnMHhOd0RaTGpyME1sQ3ZDa0JVMG8zU1NTU19UczBySXRMNnA2TnZVOQ?oc=5\" target=\"_blank\">BioXcel Therapeutics CEO Discusses AI-Driven Neuroscience Pipeline at Virtual Investor Event</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>", "publishedAt": "Wed, 13 Aug 2025 11:00:00 GMT"}, {"title": "BioXcel Therapeutics receives FDA feedback ahead of planned pre-sNDA meeting - Investing.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMiywFBVV95cUxOaGxhYWhyR3l0ZkRaa0tHT1JyX2JyRm9xa0ZFWU5yblU4WlI1a01PU2tUeWJRcGEwdWFGM0k1aU5tS2s3MHFEWjg4MElTSFZHbzlnYkRuRU5VTVREaE1YVmdFX2lhYzZxZGhXam9KTVFkazl5SjhKV3VDOGVtUE1zbkpZVk5leGFhTExhZ09GNVJTVmJhb1pYS2dENzNlMUQwYVJSOWpGblFRb2F1SmJNb042NmRDZ3RoQ3FrZ1Z5c3NIM2twa2NkdnljOA?oc=5\" target=\"_blank\">BioXcel Therapeutics receives FDA feedback ahead of planned pre-sNDA meeting</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>", "publishedAt": "Fri, 15 Aug 2025 13:33:09 GMT"}, {"title": "BioXcel Therapeutics Raises $30.4M, Meets Financing Covenant - TipRanks", "description": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxNcUJSU2FDZFBzQjZJdkUyUkhkQWRhTVdIX3YtUXhpeUdMYW1XTzRnV2cwQjBjVS1KM1Z2Y1dJbjIzRm5Wd1lqX2RaZzNYc0pZR1NOLXhtUGxLNm9kMG5yY3JDckFtVlVLT2ltamxJckczZUk2ZlhGMXptU2t5aWY1STZMWDUtd0xwNjFmUGpETVBveXJETU5CUTh3MDY5S0pTZklvVDhGRnZhaHhBOGFj?oc=5\" target=\"_blank\">BioXcel Therapeutics Raises $30.4M, Meets Financing Covenant</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>", "publishedAt": "Mon, 11 Aug 2025 21:36:38 GMT"}, {"title": "BioXcel Therapeutics (BTAI) Stock Is Extremely Volatile Today: What's Going On? - Benzinga", "description": "<a href=\"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOLVd2bGNPX1NNLXBiQUtaUUE3RWVQZG4wVF9aVjF2eVZxT3NKZDVVTVV2ZVZuV00xVGRjZzRhWm5va3ZjbVZVaTVEQXhKRWVUdHlrUFRqMTlueUZHTnJfQTQwQ2YtWENmRXJOR0NSbjd1T3NKTkUxTWdYNHFYWTB6SDRrb01QSGx2ZlJBZmU0dkJsNTdsOVFpVFVoTVZyci03ZExwcDZvU21hRFJJXzFVeU1RVzhhSS1LZ05oR3VFVV9uZUdvbTRHZlhLeUtGSTE3?oc=5\" target=\"_blank\">BioXcel Therapeutics (BTAI) Stock Is Extremely Volatile Today: What's Going On?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>", "publishedAt": "Tue, 12 Aug 2025 17:02:45 GMT"}, {"title": "BioXcel Therapeutics Inc Reports Q2 2025 Earnings: EPS of -$1.56, Revenue Misses Estimates at $120K - GuruFocus", "description": "<a href=\"https://news.google.com/rss/articles/CBMizAFBVV95cUxNb2Q5dWVUSUxhN0R1TE5qSnpRZk5FQUV5VExTSXJBb053OVlPOTZjbDQ0UHd4ZlNmTTFCU28wR3VkZjBOaVJmdmlyNll5dXVtM1d0ZFU4Y3h0OWNLaGJ2ZjJTUGZTaFpTejRka3k3eUlqUkFLNmRkbjFZV1psX0w3cW0tUnpLYmMzbGdtRGRiZzhpT3NtNUEwUFNIR2gwZWZDeVg1dmRXeC04cFg2NFFtMHVtMWg0SVBQNHpYelZWS0dvVjJsWko3NGppc3g?oc=5\" target=\"_blank\">BioXcel Therapeutics Inc Reports Q2 2025 Earnings: EPS of -$1.56, Revenue Misses Estimates at $120K</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>", "publishedAt": "Tue, 12 Aug 2025 12:31:20 GMT"}, {"title": "BioXcel Therapeutics to Participate in Canaccord Genuity Growth Conference - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxPWFo1QTFKOGZKQlNRS2dVZ2hSSzRseXMyTFFZWlAtVWJkV2xLVkJlblY1SzhFZTJ6RGxXTTlxaWxzQWc2eXdScEhpSVExVEVHZmNCdmtTMXFaR2JYNk9FUHZ4d1hRQzNXcFlSeHU0UlpQSV9NVndMVVZvbGRsRW1CRHU4UlhlSWtRZVB0SGF4TDV1WUpFV1lPRjBWV2ZsbE1tb0ZSUThn?oc=5\" target=\"_blank\">BioXcel Therapeutics to Participate in Canaccord Genuity Growth Conference</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Mon, 11 Aug 2025 22:01:34 GMT"}, {"title": "Bioxcel Therapeutics Sees Significant Market Potential for BXCL501 in Treating Agitation Episodes - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQVVlYVnVVb2Q2cHczYjBKREpMMmQ5eTZMUWhsdlNXelpvU192Ym9QQTBfTGJOck5IY1pkRTVRNGNWU0RRY3lOOW56bmZKcUE3elpHckpkOW1HcHhQQXFBWHNtWkZ2SFBpd0doZGNOMVJVM3RnQkV2QnlpRk9JcUk2eFdZdk5wRTJVek9RUU4xc3N6cVlfazlHbk00YmFWRFdxamFpWW51enNkcXpwUHljQTdmY205RWFya1NxYTZyaTZGTWM?oc=5\" target=\"_blank\">Bioxcel Therapeutics Sees Significant Market Potential for BXCL501 in Treating Agitation Episodes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Wed, 13 Aug 2025 01:54:24 GMT"}, {"title": "BioXcel Therapeutics, Inc. SEC 10-Q Report - TradingView", "description": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxOWVNfTzBXVXhiWHUtUFdGQkRsQjNBRmJ5Mkg5eE5TSTZIejhGRWhMTlBORzNWVUk3TEF6cWEwZXg4bjk1d1RsbGxzN1pRXzJ3Wk5oTG1kSWJ2LWFHNnR6ZGVqQWZLdHV4c3hNaFpSVzRhZ21qZjdDNEtXOFJPRmlNdUVsczZKTWtlanVTSFowSzU1cnBCLWZxZENLU2dzY1puMlB4ZA?oc=5\" target=\"_blank\">BioXcel Therapeutics, Inc. SEC 10-Q Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>", "publishedAt": "Tue, 12 Aug 2025 13:13:00 GMT"}, {"title": "BioXcel Therapeutics CEO to participate in virtual fireside chat on Aug 14, 2025. - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc01YZTc1QXJ6YlNwNFV3S2pLcjNiZnJlOEpZdktwcFhFVndFZWZpSDZIX1pwNzZMWFN0QVhxYWxlYnBIa0dqMHZTSVp0dDNpYmloTjVoZnctZkdnVEp0eUlnSUVQNng3N1BvcWoxc2lqdGdSTDJFVldoeGZQS3VnRkltQWJGSHJhaXkwc0pVeXVwS3FaS2JvSHc2T3Z1czJVMlFCa3hVN2U?oc=5\" target=\"_blank\">BioXcel Therapeutics CEO to participate in virtual fireside chat on Aug 14, 2025.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Wed, 13 Aug 2025 11:04:34 GMT"}, {"title": "BioXcel Therapeutics Reports Q2 2025 Financials, Topline Data Expected in August. - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxObFJSLUoyUFBiSHdBUkZmMGhYSE5YR3dWQ0dUanBIVndrT3JOYjl4cmtCSTJXOGxmMnI1X1p5YkxzNWowZWpLT2VpN0NpZE1MdW5ObzJGcjAtZkg4WUVPa3NSRWpmc1ZTX2gyMlp4RjM0UEpMQURkWWkzLTVNVEhxYm5zMUhyOGt2UU1UX2ZoR0xNb1VseDBHQS00dU9tejZvY2d6eF91emJtMEtsMFd0Sw?oc=5\" target=\"_blank\">BioXcel Therapeutics Reports Q2 2025 Financials, Topline Data Expected in August.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Tue, 12 Aug 2025 12:26:03 GMT"}, {"title": "BioXcel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Updates - TradingView", "description": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNZS1YUVdPYzBWYUlJXzJ1TmZRdXVVN0d4SWNzTzhFbWp5bDI2anU2RjFyYWMwWFNJOHJpMVcyQnFzVVNVOWwzTFdXR1N2NnNQVTdVRWVGcV9HcDB3bC1xMGlOQWtISzdtdnQ3ejlfYVlnM19XNmVBRGNaWWk2YlRMbXNyTTVPeXFqU3QxQzhQUnAzVHdLbkpsX2xIWEtaTmQxTnRFcWo4eDlrREMyak1xR2xMNHkyOTZMdEVld0l6T2xVSGh4MmMtZm5wNlE1SDhYZG5nRS1MRFpMWnRPc19ZSW1CcEh5OHphR1Vieg?oc=5\" target=\"_blank\">BioXcel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Updates</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>", "publishedAt": "Tue, 12 Aug 2025 12:15:00 GMT"}, {"title": "BioXcel Therapeutics CEO to speak at Canaccord Genuity Growth Conference. - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxQb0pQVlVrVjRndTJadVBfMFJiYV9LQV9rVjhFVkhRQzJNZDR3dnVKOTZpUkJYcHJ5Q3BCTFM5S3NIVUJWMkZwSjlxemFDZFdjTWxTZE55T1R4dDBzaVEybU51c01LV1RKRkJab21OTnVSbVlQQWNhVi1KSEhBaVFUUklZYURDbXZ0QzNFajNGVkxFQ3hBU2t2a3RDZS02V2hWVEFV?oc=5\" target=\"_blank\">BioXcel Therapeutics CEO to speak at Canaccord Genuity Growth Conference.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Mon, 11 Aug 2025 11:04:35 GMT"}, {"title": "BioXcel Therapeutics (BTAI) Q2 Financial Report: Wider Loss, Revenue Decrease, and Upcoming Business Updates - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMizwFBVV95cUxOa2EwRHJEWDlfQXVVQlo2ZEdRdzJjTnI4Q3hKeWs4bWo0Y3dSWWxia2YxRzR3Y09mY1NpWFdSRlFYNmQ3VTAwaHhxQU1oNDJ5SEJ3R2Iya29oX3Y3OEJwU0hsOHotWk5vSWhDeFlzTDhyU0pjVnBhQkpTbEhoMVQ5Uk10Q3FKWnFqQWtnRHhyaEJSbFoxQzRBVzdYMVpoaUFvU3F4cjRLcWxDaWNhVVl4MGZ1bHNHYThvM05KZVBaeUhPakVPOG1HM1NkTm1jb1k?oc=5\" target=\"_blank\">BioXcel Therapeutics (BTAI) Q2 Financial Report: Wider Loss, Revenue Decrease, and Upcoming Business Updates</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Tue, 12 Aug 2025 17:08:23 GMT"}, {"title": "Mizuho Slashes BioXcel Therapeutics\u2019 Price Target, Citing Neutral Outlook - timothysykes.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxNT1hramQ2YTBYZXdrYWs0cHpvalFISFFwSU9FSUtONjZDcTM0VVVqZV83bGxYTEFWb3lueDEtbE1pOTdDS0VHaDZ4YmVCenlTTXk2WURJNGJnel9qNTFnakptWG1KUUx5VmxsSTY0MG9DeERFRnNRUUNKS3NSYVQ1bUtUYmdVQ1U?oc=5\" target=\"_blank\">Mizuho Slashes BioXcel Therapeutics\u2019 Price Target, Citing Neutral Outlook</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">timothysykes.com</font>", "publishedAt": "Wed, 13 Aug 2025 15:32:00 GMT"}, {"title": "BioXcel Therapeutics Reports Q2 Earnings, SERENITY At-Home Trial Topline Expected in August. - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNbW5HcEkybWFDamJzOVQzWXEtX2ZzWjVZYk5mejQ5ZjNLYjRzUE9yMFdkSmpzNVQ3ZHJMNWxoR2ZURkU5WFJJMHp5Y0oxNGw3cXdEaUdYbVJYRzhuVFJVbWFWT0s1RHFWTnk0dm14aWpGclBRWWtKZGxhS0Yxc0JMNl95X1ZwaTZjdTJEeVV5cUZJVS1RdkFwYU5LaUJzdWtmZnNBRllTRjdVTFdzYXAyYXV3aDdGYTJFeUk0?oc=5\" target=\"_blank\">BioXcel Therapeutics Reports Q2 Earnings, SERENITY At-Home Trial Topline Expected in August.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Tue, 12 Aug 2025 12:01:03 GMT"}, {"title": "Bioxcel Therapeutics shares rise 4.69% premarket after CEO to participate in Canaccord Genuity conference. - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMixgFBVV95cUxNcnBYSldFTzRiNkJXeTU4WVNYQm9xMWMwREVHem94WVRVTjR5dWhWMVYwMGJVVWFyY0x3dDhyZm1fS1ctcW44UzVsakZXQlFvQWNuMVJXVVM0dldEbmZ4WTJjOGtQVGUwT0ZySGUyUWZjUDlyRkc0elVnTlRPTjk4MF9WRy1ETVc0a2VJLVpJNDNMeTgtMmNCRlFGbnh1Q0g4Ukx5WmNNd2ZrazNYb01qdGM0elVUci1rbjhYSmQtWTVBbmJJMFE?oc=5\" target=\"_blank\">Bioxcel Therapeutics shares rise 4.69% premarket after CEO to participate in Canaccord Genuity conference.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Tue, 12 Aug 2025 09:28:26 GMT"}, {"title": "HC Wainwright Adjusts Price Target on BioXcel Therapeutics to $10 From $8, Maintains Buy Rating - MarketScreener", "description": "<a href=\"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQNS0zSWx6Y05RMlJOMG1DR3F4RlYyS08zbzBnMlpHUHhZMXduT3lUUTBpNFhXT1hwZ2VKSE9DOW01WUFCMHJ0VkRPUUNwaS0wX2sxLXIzbjFCSW1MRTN3WnVJT2ZkNmVqaDI3Tkg1V0RaLWVES3FlTHNEWlVqTWp3ZWphS1NPMnQxQ2lYYzNXa0xVNVRsU2QyTmExeGRFM1VUNFZDQmN4U0ZUSlI4akk2QnNlMU5lNmM2LXZGSEhGMmw2cVZOcEhIY1ptdlNMOHV0MjJUeXNhcEs4dXdEaFE?oc=5\" target=\"_blank\">HC Wainwright Adjusts Price Target on BioXcel Therapeutics to $10 From $8, Maintains Buy Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketScreener</font>", "publishedAt": "Fri, 15 Aug 2025 14:05:07 GMT"}]